Olema Pharmaceuticals, Inc.
OLMA
$13.59
-$0.23-1.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -53.09M | -46.06M | -42.22M | -43.78M | -30.39M |
| Total Depreciation and Amortization | 119.00K | 187.00K | 43.00K | 132.00K | 128.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.18M | 3.41M | 3.23M | 3.27M | 2.56M |
| Change in Net Operating Assets | -2.19M | 4.14M | 4.42M | 10.50M | -16.28M |
| Cash from Operations | -45.99M | -38.33M | -34.53M | -29.88M | -43.98M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.53M | -162.18M | 17.27M | 34.23M | -45.08M |
| Cash from Investing | 4.53M | -162.18M | 17.27M | 34.23M | -45.08M |
| Total Debt Issued | -- | 0.00 | 0.00 | 3.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.37M | 226.66M | 41.00K | 982.00K | 236.00K |
| Repurchase of Common Stock | -4.41M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -262.00K | -13.11M | 0.00 | -6.50M | -14.00K |
| Cash from Financing | 45.70M | 213.55M | 41.00K | -2.52M | 222.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.25M | 13.04M | -17.21M | 1.83M | -88.84M |